在5年内阻塞性睡眠呼吸暂停的症状亚型进展
Jonna L Morris1, Paul W Scott1, Ulysses Magalang2
1School of Nursing, University of Pittsburgh, Pittsburgh, Pennsylvania.
概括
阻塞性睡眠呼吸暂停 (OSA) 的症状可以在五年内发生变化,近一半的患者在症状亚型之间过渡. 年龄,性别和BMI影响这些症状转移,而不是呼吸暂停-呼吸暂停指数.
科学领域:
- 睡眠医学 睡眠医学
- 呼吸系统医学 呼吸系统医学
- 临床研究 临床研究
背景情况:
- 阻塞性睡眠呼吸暂停 (OSA) 是一种常见的疾病,症状进展不明.
- 需要进行长度研究来跟踪症状变化,并确定OSA患者的影响因素.
研究的目的:
- 在5年的时间内调查阻塞性睡眠呼吸暂停症状亚型的变化.
- 在患有OSA的个体中识别症状转变的预测因素.
主要方法:
- 隐性类别分析被用于定义4种OSA症状亚型,用于睡眠心脏健康研究的2,643名参与者.
- 分析了基线和5年随访的数据,包括14种特定症状.
- 多项逻辑回归研究了年龄,性别,BMI和呼吸暂停-呼吸暂停指数对症状类过渡的影响.
主要成果:
- 在基线和随访时确定了四种OSA症状亚型 (最小症状,睡眠障碍,中度睡眠,过度睡眠).
- 近一半 (44.2%) 的参与者在5年内过渡到不同的症状亚型,过渡到"适度睡眠"是最常见的.
- 高龄,女性性别和BMI增加与特定症状亚型过渡有关,而呼吸暂停-呼吸暂停指数的变化没有预测过渡.
结论:
- 阻塞性睡眠呼吸暂停症状随着时间的推移而变化,具有波动和稳定的潜力.
- 了解OSA症状进展可以帮助临床医生为患者做出明智的治疗决定.
相关概念视频
Sleep Apnea
140
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
140
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Other Pulmonary Disorders
820
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
820


